Central Hospital in Finland Automates Symptom Tracking of Coronavirus-Infected Patients' with Help of an App

Buddy HealthcareThis November Central Ostrobothnia Central Hospital in Finland has started symptom tracking and remote monitoring of corona virus-infected patients with the Buddy Healthcare mobile application and clinical monitoring platform. The patient management platform digitizes and automates the symptom tracking process and enables secure two-way communication between patients and healthcare professionals.

The well-being of coronavirus-infected patients can change quickly, and therefore daily monitoring of symptoms is essential. After a patient has been diagnosed with a coronavirus infection, the Central Ostrobothnia Central Hospital's infectious disease unit provides the patient with instructions on downloading the BuddyCare mobile application to a smartphone or a tablet.

Coronavirus-infected patients are being asked to submit daily symptom tracking questionnaires through the mobile app over a two week period. If the healthcare professional's set thresholds are exceeded, the infectious disease unit receives an alert on their dashboard. In addition to the symptom tracking feature, patients receive information related to the coronavirus infection, and they can send questions to care personnel through secure real-time messaging. The mobile application and remote patient monitoring dashboard bring peace of mind to the patients as they know that their well-being and symptoms are being monitored every day.

Digitized symptom tracking through the mobile application helps the Central Ostrobothnia Central Hospital in automating the collection and monitoring of symptom tracking questionnaires. Previously, the hospital was contacting infected patients daily by telephone and the data was being entered manually into hospital files. The use of the BuddyCare platform decreases the need to manually track symptoms through telephone calls.

The BuddyCare patient management platform has previously been used to educate, support and monitor surgery patients before and after procedures, recently expanding to other traditional medical specialties. During spring 2020, Buddy Healthcare published its COVID-19 symptom tracking and remote patient monitoring features to support hospitals during the coronavirus pandemic.

Read more about Buddy Healthcare's solution to track and monitor coronavirus-infected patients.

About Buddy Healthcare

Buddy Healthcare is a European based digital health company specialising in automating hospitals’ care co-ordination and patient communication processes. The company was founded in 2016 and the care co-ordination platform was co-created in collaboration with university hospitals in Finland.

The company initially started producing intelligent and automated surgical care pathways, but it has rapidly expanded to other medical specialities. With the help of the Platform hospitals can guide, monitor and manage patients’ care pathways. The Plaform collects automatically forms and questionnaires such as pre-assessment forms, patient-reported outcome measures (PROMs) and patient-reported experience measures (PREMs).

The BuddyCare software has the CE mark and is GDPR and HIPAA compliant.

Most Popular Now

Significant Disparities in Telemedicine …

After "COVID-19," the term that most people will remember best from 2020 is likely to be "social distancing." While it most commonly applied to social gatherings with family and friends...

Model Used to Evaluate Lockdowns was Fla…

In a recent study, researchers from Imperial College London developed a model to assess the effect of different measures used to curb the spread of the coronavirus. However, the model...

New Virtual Screening Strategy Identifie…

A novel computational drug screening strategy combined with lab experiments suggest that pralatrexate, a chemotherapy medication originally developed to treat lymphoma, could potentially be repurposed to treat COVID-19. Haiping Zhang...

Using Artificial Intelligence to Find Ne…

Scientists have developed a machine-learning method that crunches massive amounts of data to help determine which existing medications could improve outcomes in diseases for which they are not prescribed. The intent...

FDA Releases Artificial Intelligence / M…

Today, the U.S. Food and Drug Administration released the agency's first Artificial Intelligence/Machine Learning (AI/ML)-Based Software as a Medical Device (SaMD) Action Plan. This action plan describes a multi-pronged approach...

One in Four Doctors Attacked, Harassed o…

While many physicians benefit from social media by networking with potential collaborators or interfacing with patients, a new study from Northwestern University and the University of Chicago found many physicians...

CliniSys Launches Laboratory Information…

CliniSys has launched a new laboratory information management system for genomic laboratories in the UK. The company has brought GLIMS Genomics to the UK from Europe, where it is being...

The Institute of Healthcare Management C…

The Institute of Healthcare Management has called for honest and open communication about NHS capacity after a snapshot survey revealed the scale of sickness absence across the service. The UK's leading...

First NHS Trust and Sectra Achieve Rapid…

A new region-wide approach to analysing x-rays, MRI scans, CT scans, mammography, and an entire range of crucial diagnostic images, has started to become reality, now that The Pennine Acute...

Abbott to Launch the NeuroSphere™ myPath…

Abbott (NYSE: ABT) today announced the upcoming launch of NeuroSphere™ myPath™, a digital health app designed to track and report on patient perceived pain relief and general well-being associated with...

Bayer Transforms Pharma Business through…

At its virtual Pharma Media Day, Bayer presented exciting progress in transforming its pharmaceutical business with breakthrough innovation in healthcare that will significantly help patients suffering from conditions that are...